Research activities
Centre for adult primary immunodefiency

Tumour Immunology, Cellular and Gene Therapy


Group leader: Professor Hans Stauss

Leader Main interest
Dr Emma Morris
  • Novel approaches to antigen-specific T cell therapies
  • TCR Gene Therapy
  • Clinical translation and Phase I trials

Summary of research

Figures

Figure 1 Figure 2 Figure 3
     
Figure 4 Figure 5 Figure 6



Funding: Leukaemia Research Fund, Medical Research Council, Cancer Research UK, The Dinwoodie Trust, AICR.

Selected publications

Group members:

Prof Hans Stauss
MD PhD
Professor and Head of Department
h.stauss@medsch.ucl.ac.uk
Dr Emma Morris
PhD, MRCP, MRCPath.
Senior Lecturer and Hon Consultant
e.morris@medsch.ucl.ac.uk
Dr Shao-an Xue
PhD
Senior Post Doc
s.xue@medsch.ucl.ac.uk
Dr Liquan Gao
MD
Senior Research Fellow
l.gao@medsch.ucl.ac.uk
Dr Sharyn Thomas
PhD
Post Doc
s.thomas@medsch.ucl.ac.uk
Dr Michela CescoGaspere
PhD
Post Doc
m.cescogaspere@medsch.ucl.ac.uk
Dr Christina Cellerai
PhD
Post Doc
c.cellerai@medsch.ucl.ac.uk
Dr Dan Hart
MB ChB, MRCP
Clinical Research Fellow
d.hart@medsch.ucl.ac.uk
Dr Judy King
MA, MBBS, MRCP
Clinical Research Fellow
j.king@medsch.ucl.ac.uk
Mr Aristotle Tsallios
MSc
PhD Student
a.tsallios@medsch.ucl.ac.uk
Mr Graham Wright
BSc
PhD Student
g.wright@medsch.ucl.ac.uk
Ms Constandina Pospori
IBSc
MB PhD Student
c.pospori@medsch.ucl.ac.uk
Mr Mario Perro
MSc
PhD Student
m.perro@medsch.ucl.ac.uk
Ms Angelika Holler
MSc
Technician
a.holler@medsch.ucl.ac.uk
Ms Theres Matjeka
MSc
Visiting Student
t.matjeka@medsch.ucl.ac.uk
Mrs Eira Rawlings
MSc, HND
Laboratory Manager
e.rawlings@medsch.ucl.ac.uk

 

Molecular Genetics of Primary Immunodeficiencies


Group leader: Professor Bodo Grimbacher

Leader Main interest
Dr Erik Glocker
  • The genetic causes of primary antibody deficiencies
  • Positional Cloning and Linkage Analysis
  • Infections in the immunodeficient host, Microbiology
Dr Gabriela Lopez-Herrera
  • The genetic causes of primary antibody deficiencies
  • The role of TACI in CSR and SHM
Dr Karin Engelhardt
  • The genetic cause of autosomal-recessive hyper-IgE recurrent infection syndrome
  • New disease genes in severe congenital neutropenia
  • Positional Cloning and Linkage Analysis
Miss Cristina Woellner
  • The genetic cause of Hyper IgE Syndromes
  • Role of Th17 cells in the pathophysiology of primary immunodeficiencies
Ms Jennifer Birmelin
  • TACI polymorphisms in autoimmunity and lymphoprolipheration
  • Linkage analysis of CVID families
Miss Viviane Knerr
  • Clinical online registries
  • The UKPIN registry
  • The ESID registry
Mr David Guzman
  • Clinical online registries
  • Data mining
  • database development


Summary of research

Funding:

European Commission:
Marie-Curie grant MEXT-CT-2006-042316 from 11/06 to 10/2010
FP7 grant EURO PADnet from 05/08 to 12/10
Primary Immunodeficiency Association:
GSK grant 2008 (P5049) from 01/08 to 12/2010
UKPIN registry grant 2007/01 from 08/07 to 07/2010
National Institutes of Health:
USIDnet grant N01-A1-30070 from 11/06 to 12/07
USIDnet grant Contract Officer Approval 39 from 04/07 to 09/08.

 

Selected publications

Links: www.esid.org

Group members:

Prof Bodo Grimbacher
MD
Professor, Immunology Consultant, and Head of Marie Curie Research Group
b.grimbacher@ucl.ac.uk

Dr Erik Glocker
MD
Senior Researcher
e.glocker@medsch.ucl.ac.uk

Dr Gabriela Lopez Herrera
PhD
Postdoc
g.herrera@medsch.ucl.ac.uk

Dr Karin Engelhardt
PhD
Postdoc
k.engelhardt@medsch.ucl.ac.uk

Viviane Knerr
Dipl
Database Coordinator,
Project manager for EU grants
v.knerr@medsch.ucl.ac.uk

David Guzman
Lic
Database developer
d.guzman@medsch.ucl.ac.uk

Miss Cristina Woellner
MSc
PhD-Student
c.woellner@medsch.ucl.ac.uk

Jennifer Birmelin
Research assistant and PhD student
j.birmelin@medsch.ucl.ac.uk

What is the EURO-PADnet?

EU-PADnet represents a Europe-wide multidisciplinary consortium of clinician scientists and basic researchers focussing on the documentation of the genetic and molecular cause, the natural history, and the pathophysiology of Primary Antibody Deficiencies (PADs). Most PADs are considered to be Mendelian disorders. In this proposal, we will work towards the development of novel preventive, diagnostic and therapeutic interventions. We will:
- document and monitor the course of the disease in a clinical and research online database linked to a repository (WP1)
- develop new diagnostic tools and tests, including genetic and in vitro tests (WPs 2-5)
- address preventive medicine (WPs 1 and 5)
- work towards new therapeutic approaches (WP5)
- measure the quality of life from patients with PAD and their families (WP1)
- develop in vitro models for PAD (WP3)
- develop animal models for PAD (WP4)
The acquired knowledge will provide the bases for future development of diagnostic, therapeutic and preventive approaches.

 

Dr David Webster’s group

Role of persistent virus infections in Primary Immunodeficiency

A collaborative group within the Departments of Virology and Immunology on the Royal Free Campus is investigating the immunological defence mechanisms against cytomegalovirus (CMV) infection in patients with Common Variable Immunodeficiency (CVID). Infected CVID patients often have exaggerated T cell responses to this virus, and at a clinical level this is closely associated with chronic inflammatory complications (e.g. granulomatous disease). Sensitive techniques to both assess CMV replication in tissues and to measure neutralizing antibodies are being developed to help test the hypothesis that an exaggerated T cell response is necessary to control CMV in patients who have low levels of antibodies.

Principal investigator – Prof Vince Emery, PhD student- Madhi  Marashi   (Virology)

Collaborators – Prof Bodo Grimbacher, Dr David Webster, Mohammad Raeiszadeh (Research Assistant)  (Immunology)